Movement Alert｜Kodiak Sciences Inc. Declines 5.08% in Regular Trading, Trading at $93.76

Market Focus

Oct 02

On October 2, Kodiak Sciences Inc. fell 5.08% in regular trading, trading at $93.76 USD/share, with Turnover of $31.66 million.

Within the Biotechnology sector where Kodiak Sciences Inc. belongs, the overall sector performance was mixed. Among individual stocks, Moderna up 0.43%, Gilead Sciences down 0.71%, AbbVie up 0.19%, Amgen down 0.30%, Natera up 0.24%.

Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel therapeutics for chronic, high-prevalence retinal diseases. Its lead product candidates are built on a proprietary antibody biopolymer conjugate platform designed to maintain effective drug levels in ocular tissues.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/news/1121105661"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1121105661\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1121105661?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-10-02 22:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1121105661","market":"hk","top_or_hot":-1,"title":"Movement Alert｜Kodiak Sciences Inc. Declines 5.08% in Regular Trading, Trading at $93.76","media":"Market Focus","content":"<p><p>On October 2, Kodiak Sciences Inc. fell 5.08% in regular trading, trading at $93.76 USD/share, with Turnover of $31.66 million.</p><p>Within the Biotechnology sector where Kodiak Sciences Inc. belongs, the overall sector performance was mixed. Among individual stocks, Moderna up 0.43%, Gilead Sciences down 0.71%, AbbVie up 0.19%, Amgen down 0.30%, Natera up 0.24%.</p><p>Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel therapeutics for chronic, high-prevalence retinal diseases. Its lead product candidates are built on a proprietary antibody biopolymer conjugate platform designed to maintain effective drug levels in ocular tissues.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜Kodiak Sciences Inc. Declines 5.08% in Regular Trading, Trading at $93.76</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜Kodiak Sciences Inc. Declines 5.08% in Regular Trading, Trading at $93.76\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-10-02 22:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On October 2, Kodiak Sciences Inc. fell 5.08% in regular trading, trading at $93.76 USD/share, with Turnover of $31.66 million.</p><p>Within the Biotechnology sector where Kodiak Sciences Inc. belongs, the overall sector performance was mixed. Among individual stocks, Moderna up 0.43%, Gilead Sciences down 0.71%, AbbVie up 0.19%, Amgen down 0.30%, Natera up 0.24%.</p><p>Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel therapeutics for chronic, high-prevalence retinal diseases. Its lead product candidates are built on a proprietary antibody biopolymer conjugate platform designed to maintain effective drug levels in ocular tissues.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KOD","symbol_name":"Kodiak Sciences Inc.","start_time":0,"source_url":"","article_id":"1121105661","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1121105661","pubTimestamp":1790949717,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On October 2, Kodiak Sciences Inc. fell 5.08% in regular trading, trading at $93.76 USD/share, with Turnover of $31.66 million.Within the Biotechnology sector where Kodiak Sciences Inc. belongs, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"KOD":"Kodiak Sciences Inc."},"translate_title":"走势警报|Kodiak Sciences Inc. 常规交易中下跌 5.08%，交易价格为 93.76 美元","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KOD":1},"content_text":"On October 2, Kodiak Sciences Inc. fell 5.08% in regular trading, trading at $93.76 USD/share, with Turnover of $31.66 million.Within the Biotechnology sector where Kodiak Sciences Inc. belongs, the overall sector performance was mixed. Among individual stocks, Moderna up 0.43%, Gilead Sciences down 0.71%, AbbVie up 0.19%, Amgen down 0.30%, Natera up 0.24%.Kodiak Sciences Inc. is a clinical-stage biopharmaceutical company specializing in the research and development of novel therapeutics for chronic, high-prevalence retinal diseases. Its lead product candidates are built on a proprietary antibody biopolymer conjugate platform designed to maintain effective drug levels in ocular tissues.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}